The ability of lithium and other mood stabilizers to decrease suicide risk and prevent relapse.
- 1 December 2000
- journal article
- review article
- Published by Springer Nature in Current Psychiatry Reports
- Vol. 2 (6) , 490-494
- https://doi.org/10.1007/s11920-000-0007-5
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Effect of Prophylactic Treatment on Suicide Risk in Patients with Major Affective DisordersPharmacopsychiatry, 1996
- Five-year mortality in lithium-treated manic-depressive patientsJournal of Affective Disorders, 1991
- Predictors of outcome in prophylactic lithium treatment: a 2-year prospective studyJournal of Affective Disorders, 1990
- Comparison of the Prophylactic Action of Flupenthixol with Placebo in Lithium Treated Manic-Depressive PatientsThe British Journal of Psychiatry, 1986
- Flupenthixol decanoate in recurrent manic‐depressive illnessActa Psychiatrica Scandinavica, 1981
- A controlled evaluation of lithium prophylaxis in affective disordersPsychological Medicine, 1972
- PROPHYLACTIC LITHIUM IN AFFECTIVE DISORDERSThe Lancet, 1971
- EFFICACY OF LITHIUM AS ACUTE TREATMENT OF MANIC-DEPRESSIVE ILLNESSThe Lancet, 1971
- Prophylactic Lithium: A Double-Blind Trial in Recurrent Affective DisordersThe British Journal of Psychiatry, 1970
- Treatment of Manic Illness with Lithium CarbonateThe British Journal of Psychiatry, 1963